COSA has developed guidelines for the management of neuroendocrine neoplasms. These guidelines aim to raise awareness of the increasing multidisciplinary management options which may be appropriate for patients with this less common group of diseases.
We encourage you, your colleagues and the NETs community to make comments. At the end of the consultation period, the guidelines will be revised by the working group to incorporate feedback. The final version will be posted to a web-based platform in early 2023.
Click here to access the chapters.
